Neurologists
14 years of experience
Video profile
Accepting new patients
Madison Heights
27483 Dequindre Rd
Ste 306
Madison Heights, MI 48071
248-967-7988
Locations and availability (3)

Education ?

Medical School Score Rankings
Michigan State University College of Osteopathic Medicine (1996)
  • Currently 4 of 4 apples
Top 25%

Awards & Distinctions ?

Awards  
Hour Detroit Magazine's Top Docs (2010), Hour Detroit Magazine's Top Docs (2011)
Detroit Hour Magazine's Top Docs (2010)
Hour Detroit Magazine's Top Docs (2010)
Hour Detroit Magazine's Top Docs (2011)
Associations
American Association of Neuromuscular and Electrodiagnostic Medicine
American Headache Society

Affiliations ?

Dr. Fellows is affiliated with 24 hospitals.

Hospital Affilations

Score

Rankings

  • St. Joseph Mercy Oakland
    44405 Woodward Ave, Pontiac, MI 48341
    • Currently 4 of 4 crosses
    Top 25%
  • Beaumont Hospital, Grosse Pointe
    468 Cadieux Rd, Grosse Pointe, MI 48230
    • Currently 4 of 4 crosses
    Top 25%
  • Garden City Hospital
    6245 Inkster Rd, Garden City, MI 48135
    • Currently 4 of 4 crosses
    Top 25%
  • Providence Hospital and Medical Center
    16001 W 9 Mile Rd, Southfield, MI 48075
    • Currently 4 of 4 crosses
    Top 25%
  • Beaumont Hospital, Royal Oak
    3601 W 13 Mile Rd, Royal Oak, MI 48073
    • Currently 4 of 4 crosses
    Top 25%
  • Beaumont Hospital,Troy
    44201 Dequindre Rd, Troy, MI 48085
    • Currently 4 of 4 crosses
    Top 25%
  • DMC - Sinai-Grace Hospital
    6071 W Outer Dr, Detroit, MI 48235
    • Currently 4 of 4 crosses
    Top 25%
  • Huron Valley-Sinai Hospital
    1 William Carls Dr, Commerce Township, MI 48382
    • Currently 4 of 4 crosses
    Top 25%
  • St. John Macomb-Oakland Hospital (Macomb Center)
    11800 E 12 Mile Rd, Warren, MI 48093
    • Currently 3 of 4 crosses
    Top 50%
  • St. John Macomb-Oakland Hospital (Oakland Center)
    27351 Dequindre Rd, Madison Heights, MI 48071
    • Currently 3 of 4 crosses
    Top 50%
  • St John Detroit Riverview Hospital
    7733 E Jefferson Ave, Detroit, MI 48214
    • Currently 3 of 4 crosses
    Top 50%
  • Harper University Hospital
    3990 John R St, Detroit, MI 48201
    • Currently 3 of 4 crosses
    Top 50%
  • Detroit Receiving Hospital & University Health Center
    4201 Saint Antoine St, Detroit, MI 48201
    • Currently 3 of 4 crosses
    Top 50%
  • Botsford Hospital
    28050 Grand River Ave, Farmington Hills, MI 48336
    • Currently 2 of 4 crosses
  • POH Medical Center
    50 N Perry St, Pontiac, MI 48342
    • Currently 2 of 4 crosses
  • Troy
  • Henry Ford Medical Center at Maplegrove
    6777 W Maple Rd, West Bloomfield, MI 48322
  • St. John MacombOakland Hospital
  • Troy (8 Years
  • Royal Oak (11 Years
  • Signature Healthcare Brockton Hospital
  • Sinaigrace Hospital
  • Royal Oak
  • Providence Park Hospital
    47601 Grand River Ave, Novi, MI 48374
  • Publications & Research

    Dr. Fellows has contributed to 5 publications.
    Title Using Radon Risk to Motivate Smoking Reduction Ii: Randomized Evaluation of Brief Telephone Counseling and a Targeted Video.
    Date June 2008
    Journal Health Education Research
    Excerpt

    Radon and cigarette smoking have synergistic effects on lung cancer risk. Electric utility company bill stuffers offered free radon test kits to households with at least one smoker. Participating households (n = 1364) were randomized within a 2 x 2 design to evaluate the main effects of brief telephone counseling and a targeted video on smoking cessation and the establishment of new household smoking bans. Phone counseling was associated with cessation at 3-month follow-up but neither intervention led to 12-month or sustained cessation. While neither intervention had a significant effect on new bans, there were trends in the predicted direction and the combination of the two significantly increased new bans compared with no intervention. The presence of children in the household was associated with new bans. While few households had high levels of radon, such levels were associated with radon mitigation behaviors. Together with a previous study, these results suggest radon risk is a useful and inexpensive way to engage smoking households in risk reduction behaviors, especially the institution of household smoking bans.

    Title The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: a Further Report with 7 Years of Follow Up.
    Date June 1996
    Journal The Journal of Urology
    Excerpt

    Purpose: We determined the role, if any, of 1 and 5 instillations of intravesical mitomycin C in the treatment of newly diagnosed superficial bladder cancer. Materials and Methods: A multicenter randomized clinical trial was done involving 502 patients with newly diagnosed superficial bladder cancer. After complete transurethral resection patients with newly diagnosed superficial bladder cancer. After complete resection patients were randomized into 1 of 3 treatment arms: no further treatment, 1 instillation of mitomycin C at resection and 1 instillation at resection and at 3-month intervals for 1 year (total 5 instillations). The dose of mitomycin C used was 40 mg./40 ml. water. End points were interval to first superficial recurrence, recurrence rate (defined as the number of positive cystoscopies per year) and progression-free interval rate (progression defined as the development of muscle invasive or metastatic disease, or death from bladder cancer). Results: After median followup of 7 years 1 and 5 instillations of mitomycin C resulted in decreased recurrence rates and increased recurrence-free interval. The benefit of mitomycin C was observed in patients at low, medium and high risk for subsequent recurrence. There was suggestive but not conclusive evidence that 5 instillations of mitomycin C offered a slight advantage over 1 instillation. Conclusions: Our analysis confirms the positive benefit of mitomycin C to decrease the number of subsequent recurrences and increase the recurrence-free interval.

    Title Localization of Insulin-like Growth Factor Binding Protein-4 Expression in the Mouse Uterus During the Peri-implantation Period.
    Date January 1996
    Journal Biology of Reproduction
    Excerpt

    Previous studies have suggested a role for insulin-like growth factors (IGFs) in both embryo and trophoblast growth, as well as in uterine differentiation. Included in the IGF family are the IGF binding proteins (IGFBPs). In the current study we have demonstrated, by Western ligand blot of mouse uterine tissue extracts, a dramatic increase in IGFBP-4 at the time of embryo implantation. As an extension of this finding, we used in situ hybridization to examine the ontogeny and anatomical localization of IGFBP-4 mRNA in the mouse uterus during the peri-implantation period. On gestational Day 2, while the embryos are still in the oviduct, no uterine IGFBP-4 mRNA signal was observed. However, on gestational Day 4, when the embryos are free in the uterine lumen, IGFBP-4 mRNA was present in the uterine stroma underlying the luminal epithelium. By gestational Day 6, approximately 24 h after implantation, a IGFBP-4 mRNA signal was intense at each implantation site and extended throughout the decidua. A signal was absent in the uterine tissue between implantation sites. By gestational Day 8, the IGFBP-4 mRNA signal was reduced and confined to the stroma nearest the myometrium. The specific anatomical and temporal nature of the IGFBP-4 mRNA expression suggests a physiologic role for this binding protein in the implantation process.

    Title Familial Occurrence of Testicular Cancer.
    Date April 1994
    Journal The Journal of Urology
    Excerpt

    The etiology of testicular cancer is unknown. Familial testicular cancer is a rare entity that adds further information to research regarding the genetic influence on germ cell tumors. We report on 5 brothers, including 2 identical triplets and 1 fraternal brother, with testicular cancer and discuss the epidemiological factors. It appears that environmental and genetic factors must be considered.

    Title The State of Cost-effectiveness Analysis in American Managed Care.
    Date
    Journal Expert Review of Pharmacoeconomics & Outcomes Research
    Excerpt

    In 1996, the US Panel on Cost-Effectiveness in Health and Medicine published detailed recommendations for the conduct and use of cost-effectiveness analyses (CEA) of medical technologies. These recommendations were expected to promote the use of CEA to inform the resource allocation decisions of a diverse audience including, among others, American managed care organizations. Yet, nearly 10 years later, the limited explicit use of CEA in the USA remains a prominent discussion topic, with few signs of resolution. Its limited use within managed care is especially striking given the industry's stated interest in efficient healthcare and historically unstable finances in the face of continually rising healthcare costs.


    Similar doctors nearby

    Dr. Louis Rentz

    Neurology
    50 years experience
    Madison Heights, MI

    Dr. Michelle Mora-Wiley

    Neurology
    Madison Heights, MI

    Dr. Lateya Foxx

    Neurology
    Madison Heights, MI

    Dr. Blair Young

    Neurology
    Madison Heights, MI

    Dr. Richard Gargulinski

    Neurology
    21 years experience
    Madison Heights, MI

    Dr. Paul Finkel

    Neurology with Special Qualifications in Child Neurology
    38 years experience
    Madison Heights, MI
    Search All Similar Doctors